Managing Advanced Stages of Friedreich’s Ataxia: Challenges and Emerging Therapeutic Avenues : Episode 11
Opinion
Video
Clinical Utility of the Modified Friedreich Ataxia Rating Scale
Author(s):
Key Takeaways
- mFARS is designed to assess Friedreich Ataxia progression in clinical trials, focusing on motor function and disease severity.
- Its complexity and time requirements may limit routine use in everyday clinical practice.
Sub Subramony, M.D., discusses how the modified Friedreich Ataxia Rating Scale (mFARS) is valuable for monitoring disease progression in clinical trials and its applicability in everyday clinical practice for assessing patient status.
Video content above is prompted by the following:
The modified Friedreich Ataxia Rating Scale (mFARS) has been developed to monitor FA disease progression in clinical trials. Is mFARS useful in your everyday clinical practice?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Videos
